参考文献/References:
[1] SUN Z,XU Q,GAO G,et al.Clinical observation in edaravone treatment for acute cerebral infarction[J].Niger J Clin Pract,2019,22(10):1324-1327.
[2] SHIBATA K,HASHIMOTO T,MIYAZAKI T,et al.Thrombolytic therapy for acute ischemic stroke:past and future[J].Curr Pharm Des,2019,25(3):242-250.
[3] TAKAMIYA Y,OKAMURA K,SHIRAI K,et al.Multicenter prospective observational study of teneligliptin,a selective dipeptidyl peptidase-4 inhibitor,in patients with poorly controlled type 2 diabetes:focus on glycemic control,hypotensive effect,and safety Chikushi Anti-Diabetes Mellitus Trial-Teneligliptin(CHAT-T)[J].Clin Exp Hypertens,2020,42(3):197-204.
[4] 刘新峰,刘锐.脑梗死急性期的血管内介入诊疗[J].中华神经科杂志,2020,53(5):372-375.
LIU X F,LIU R.Endovascular treatment for acute ischemic stroke[J]. Chin J Neurol, 2020,53(5):372-375
[5] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.
DIABETES BRANCH OF CHINESE MEDICAL ASSOCIATION.Reaction to guideline for the prevention and treatment of type 2 diabetes mellitus in China (2017 edition)[J].Chin J Diabetes Mellitus,2018,38(4):292-344.
[6] 饶明俐.中国脑血管病防治指南:试行版[M].北京:人民卫生出版社,2007:15-18.
RAO M L.Chinese guidelines for prevention and treatment of cerebrovascular diseases:trial version[M].Beijing:People′s Health Publishing House,2007:15-18.
[7] 中华医学会神经病学分会,中华医学会神经病学分会神经血管介入协作组,急性缺血性脑卒中介入诊疗指南撰写组.中国急性缺血性脑卒中早期血管内介入诊疗指南[J].中华神经科杂志,2015,48(5):356-361.
NEUROLOGY BRANCH OF CHINESE MEDICAL ASSOCIATION,NEUROVASCULAR INTERVENTION COOPERATION GROUP OF NEUROLOGY BRANCH OF CHINESE MEDICAL ASSOCIATION,AND INTERVENTIONAL DIAGNOSIS AND TREATMENT GUIDE WRITING GROUP OF ACUTE ISCHEMIC STROKE.Chinese guidelines for the endovascular treatment of acute ischemic stroke[J].Chin J Neurol,2015,48(5):356-361.
[8] LEE S Y,KIM D Y,SOHN M K,et al.Determining the cut-off score for the modified Barthel index and the modified Rankin scale for assessment of functional independence and residual disability after stroke[J].PLoS One,2020,15(1):e0226324.
[9] HAN J Q,LIU C L,WANG Z Y,et al.Anti-inflammatory properties of lipoxin A4 protect against diabetes mellitus complicated by focal cerebral ischemia/reperfusion injury[J].Neural Regen Res,2016,11(4):636-640.
[10] HILLMAN T C,MATEI N,TANG J,et al.Developing a standardized system of exposure and intervention endpoints for isoflurane in preclinical stroke models[J].Med Gas Res,2019,9(1):46-51.
[11] 何超,徐翀,李远超.急性基底动脉闭塞血管内介入治疗的疗效及预后不良的危险因素[J].中国临床神经外科杂志,2019,24(7):399-401.
HE C,XU C,LI Y C.Efficacy and risk factors of poor prognosis of intravascular interventional therapy for acute basilar artery occlusion[J].Chin J Clin Neurosurg,2019,24(7):399-401.
[12] 王岩,张雪芳,李杰,等.急性缺血性脑卒中静脉溶栓治疗预后的影响因素[J].中国老年学杂志,2018,38(15):3597-3600.
WANG Y,ZHANG X F,LI J,et al.Prognostic factors of intravenous thrombolytic therapy for acute ischemic stroke[J].Chin J Gerontol,2018,38(15):3597-3600.
[13] CHALOS V,VAN DER ENDE N A M,LINGSMA H F,et al.National institutes of health stroke scale:an alternative primary outcome measure for trials of acute treatment for ischemic stroke[J].Stroke,2020,51(1):282-290.
[14] TAM D.Calculated decisions:Pediatric National Institutes of Health Stroke Scale (Ped NIHSS)[J].Pediatr Emerg Med Pract,2019,16(11):CD1-CD2.
[15] 李青松,陈珑,刘一之,等.动脉内机械取栓治疗急性后循环缺血性脑卒中临床效果及预后影响因素[J].中国介入影像与治疗学,2019,16(6):333-337.
LI Q S,CHEN L,LIU Y Z,et al.Clinical efficacy and prognostic factors of mechanical thrombectomy in treatment of acute posterior circulation ischemic stroke[J].Chin J Interv Imaging Ther,2019,16(6):333-337.
[16] JIANG Z,WANG J,ZHAO P,et al.HbA1c:high in acute cerebral infarction and low in brain trauma[J].Prog Mol Biol Transl Sci,2019,162:293-306.
[17] 吴琼,赵明,赵荟,等.节段性中重度基底动脉狭窄与后循环缺血性脑卒中的相关性研究[J].哈尔滨医科大学学报,2019,255(3):68-72.
WU Q,ZHAO M,ZHAO H,et al.Correlation between segmental moderate and severe basilar artery stenosis and posterior circulation ischemic stroke[J].J Harbin Med Univ,2019,255(3):68-72.
相似文献/References:
[1]何茶叶,刘 平,焦新彩,等.灯盏花素治疗急性脑梗死30例疗效观察[J].新乡医学院学报,2001,18(06):425.
[2]翁孝刚.2型糖尿病与胰岛B一细胞功能[J].新乡医学院学报,2002,19(03):231.
[3]汪裕荣.血脂康联合小剂量阿司匹林治疗2型糖尿病并高脂血症的长期疗效观察[J].新乡医学院学报,2002,19(05):391.
[4]型糖尿病合并高血压的胰岛素敏感性探讨.2型糖尿病合并高血压的胰岛素敏感性探讨[J].新乡医学院学报,2003,20(02):124.
[5]高连英,罗开国.降纤酶治疗急性脑梗死50例[J].新乡医学院学报,2003,20(02):143.
[6]何伟玺.冠心病与2型糖尿病患者心率变异性对比分析[J].新乡医学院学报,2003,20(04):282.
[7]李万森,毛向莹,邱培勇.2型糖尿病合并脑梗死50例临床分析[J].新乡医学院学报,2003,20(05):353.
[8]殷国田,崔瑞花.益津降糖胶囊治疗2型糖尿病42例[J].新乡医学院学报,2003,20(05):372.
[9]新乡市第二人民医院内分泌科 河南新乡.依那普利对2型糖尿病合并高血压患者血压及胰岛素敏感性指数的影响[J].新乡医学院学报,2005,22(03):267.
[10]陈娟,姬明丽.急性脑梗死患者血糖水平与梗死范围及预后的关系 [J].新乡医学院学报,2006,23(03):000.
[11]付 彦.2型糖尿病合并急性脑梗死患者颈动脉粥样硬化及血清脂联素、可溶性细胞间黏附分子-1和可溶性血管细胞间黏附分子-1水平分析[J].新乡医学院学报,2020,37(7):674.[doi:10.7683/xxyxyxb.2020.07.018]
FU Yan.Analysis of carotid atherosclerosis and the levels of serum adiponectin,soluble intercellular adhesion molecule-1 and soluble vascular cell adhesionmolecula-1 in patients with type 2 diabetes mellitus complicated with acute cerebral infarction[J].Journal of Xinxiang Medical University,2020,37(6):674.[doi:10.7683/xxyxyxb.2020.07.018]